Skip to content

HIV attachment inhibitor BMS-663068 matches atazanavir in phase 2b study

Interferon-free treatment works well for people who inject drugs, but barriers to access remain

Affordable Care Act coverage improves chances of viral suppression for Americans with HIV

No transmission of integrase inhibitor-resistant HIV seen in California patients

People who inject drugs should have access to hepatitis C treatment, expert panel recommends

People with HIV are at higher risk of several types of cancer, large study finds

New antiretrovirals and HIV treatment strategies highlighted at ICAAC

US HIV physicians routinely offering early ART but only a third have prescribed PrEP

Recent infection and ART treatment interruptions are key periods for HIV transmission